Liver diseases therapeutics market to be worth $12.1 billion by 2022; Report

The global liver disease therapeutics market is expected to reach a value of $12.1 billion by 2022, new research indicates.

According to a new report by Grand View Research, the changing lifestyle habits including increasing alcohol consumption is a vital driving force of this market. The changing dynamics in health care sector has heightened the importance of patients and practitioners treatment decision, which suggests that liver diseases therapeutics market is expected to witness lucrative growth over the forecast period.

Furthermore, the growing global base of geriatric population is likely to expand patient base. However, slow adoption rate of liver diseases therapeutics due to lack of clinical evidences and awareness is expected to serve as a key challenge for manufacturers. However, the incorporation of regulatory agencies along with favorable government initiatives and support will help improve usage rates.